# Peptide Reference Library — dosage & half-life | PepVault

Source: https://pepvault.app/peptides

Last updated: 2026-10-19

[PepVault](https://pepvault.app/) Peptides

69 peptides · free, no signup

# Peptide reference library.

The studied range, how often, half-life and evidence for each peptide, by goal. Every page adds how it works, safety notes and stacks, and a reconstitution example where one applies. A research range, never a dose for you.

By area

## Where each peptide works.

Pick an area to see the peptides used for it. An area lights for what a peptide is used for and what people report, with the evidence beside it. It isn’t a promise that it works there.

### Appetite & metabolism

25 peptides · Appetite, weight, body fat, blood sugar, insulin, liver fat

- [Cagrilintide](https://pepvault.app/peptides/cagrilintide)

  **In people.** On its own in REDEFINE 1, it averaged 11.8% weight loss at 68 weeks for people who stayed on it.
- [CagriSema](https://pepvault.app/peptides/cagrisema)

  **In people.** In its main trial people lost about 20% of body weight on average at 68 weeks, more than on semaglutide alone.
- [Dulaglutide](https://pepvault.app/peptides/dulaglutide)

  **In people.** In its 36-week trial it lowered HbA1c by 1.8 points and weight by 4.6 kg on average.
- [HGH](https://pepvault.app/peptides/hgh)

  **In people.** In healthy adults, trials show about 2 kg of fat swapped for lean mass, with no strength gain and more side effects.
- [Liraglutide](https://pepvault.app/peptides/liraglutide)

  **In people.** In the main trial, about two in three people lost at least 5% within a year on this dose.
- [Mazdutide](https://pepvault.app/peptides/mazdutide)

  **In people.** In the phase 3 GLORY-1 trial, people lost about 11% to 14% of their body weight at 48 weeks.
- [Orforglipron](https://pepvault.app/peptides/orforglipron)

  **In people.** Its top dose averaged about 11% weight loss at 72 weeks in its main trial.
- [Retatrutide](https://pepvault.app/peptides/retatrutide)

  **In people.** Its top dose averaged about 25–28% weight loss at 80 weeks in phase 3.
- [Semaglutide](https://pepvault.app/peptides/semaglutide)

  **In people.** About 15% average weight loss at 68 weeks in its main trial.
- [Semaglutide (oral)](https://pepvault.app/peptides/semaglutide-oral)

  **In people.** Used for type 2 diabetes, and as Wegovy tablets for weight management.
- [Survodutide](https://pepvault.app/peptides/survodutide)

  **In people.** Average weight loss at 76 weeks was 12–13% counting everyone and up to 16.6% for people who stayed on it.
- [Tesamorelin](https://pepvault.app/peptides/tesamorelin)

  **In people.** In two phase 3 trials it cut visceral fat about 15% in 26 weeks.
- [Tirzepatide](https://pepvault.app/peptides/tirzepatide)

  **In people.** In a head-to-head trial it produced more weight loss than semaglutide (20.2% vs 13.7% at 72 weeks).
- [AOD-9604](https://pepvault.app/peptides/aod-9604)

  **In people.** AOD-9604 showed modest weight loss in one 12-week trial, but a larger 24-week trial failed and obesity development stopped in 2007.
- [CJC-1295 no DAC](https://pepvault.app/peptides/cjc-1295-no-dac)

  **Reported by users.** More lean mass and modest fat loss, with sleep strong and consistent.
- [CJC-1295 with DAC](https://pepvault.app/peptides/cjc-1295-with-dac)

  **Reported by users.** Commonly reported in this window: measurable fat loss and lean gains.
- [Fragment 176-191](https://pepvault.app/peptides/fragment-176-191)

  **In animals.** It targets fat cells: in rodents it boosted fat breakdown without affecting blood sugar or IGF-1.
- [GHRP-6](https://pepvault.app/peptides/ghrp-6)

  **In animals.** Significantly increases appetite (shown in animals and widely reported by users) — useful for those seeking to bulk.
- [Ipamorelin](https://pepvault.app/peptides/ipamorelin)

  **Reported by users.** Some report measurable fat loss and easier joints.
- [Oxytocin](https://pepvault.app/peptides/oxytocin)

  **In people.** Single nasal doses cut food intake at a test meal and blunted stress responses in small studies, though an 8-week trial produced no weight loss.
- [Pemvidutide](https://pepvault.app/peptides/pemvidutide)

  **In people.** In a 48-week phase 2 obesity trial, average weight loss reached 15.6% on the top dose.
- [5-Amino-1MQ](https://pepvault.app/peptides/5-amino-1mq)

  **In animals.** In obese mice it cut body weight and fat without reducing food intake.
- [Humanin](https://pepvault.app/peptides/humanin)

  **In animals.** Its work is background cell protection and better insulin sensitivity, seen so far only in cells and rodents.
- [MOTS-c](https://pepvault.app/peptides/mots-c)

  **In animals.** In mice it activates AMPK, the pathway exercise triggers, improving insulin sensitivity and exercise capacity.
- [SLU-PP-332](https://pepvault.app/peptides/slu-pp-332)

  **In animals.** In obese mice it raised energy expenditure and fat burning and cut fat gain without changing what they ate.

## Healing & recovery 13

- [Ac-SDKP](https://pepvault.app/peptides/tb-500-fragment) TB-500 Fragment · TB-4 Frag · Goralatide · Thymosin Beta-4 (1-4) Studied range: 250–750 mcg How often: EOD Half-life ~4.5 min
- [AOD-9604](https://pepvault.app/peptides/aod-9604) Anti-Obesity Drug 9604 · HGH Fragment 177-191 Studied range: 250–300 mcg How often: Daily Half-life ~30 min
- [ARA-290](https://pepvault.app/peptides/ara-290) Cibinetide · ARA290 · pHBSP · Helix B surface peptide · HBSP Studied range: 1–4 mg How often: Daily Half-life ~20 minutes
- [BPC-157](https://pepvault.app/peptides/bpc-157) Body Protection Compound 157 · BPC157 Studied range: 200–500 mcg How often: 1–2× daily Half-life ~4–6 hours
- [Cartalax](https://pepvault.app/peptides/cartalax) AED peptide · Ala-Glu-Asp · Kartalax Studied range: No reference dose How often: Daily Half-life: no figure
- [GHK-Cu](https://pepvault.app/peptides/ghk-cu) Copper Peptide · GHK-Copper · Tripeptide-1 Studied range: 1–2 mg How often: Daily Half-life: no figure
- [KPV](https://pepvault.app/peptides/kpv) Lys-Pro-Val · α-MSH tripeptide Studied range: 100–300 mcg How often: Daily Half-life: no figure
- [Larazotide](https://pepvault.app/peptides/larazotide) AT-1001 · Larazotide Acetate Studied range: 0.5–1 mg How often: 3× daily Half-life: no figure
- [LL-37](https://pepvault.app/peptides/ll-37) Cathelicidin · hCAP-18 · CAP-18 Studied range: 100–300 mcg How often: Daily Half-life: no figure
- [TB-500](https://pepvault.app/peptides/tb-500) Thymosin Beta-4 Fragment · TB4 Studied range: 1–2.5 mg How often: 2× weekly Half-life ~0.5–2 hours
- [Thymosin Alpha-1](https://pepvault.app/peptides/thymosin-alpha-1) Tα1 · Thymalfasin · Zadaxin Studied range: 1–1.6 mg How often: 2× weekly Half-life ~2 hours
- [Thymosin Beta-4](https://pepvault.app/peptides/thymosin-beta-4) Tβ4 · Full TB4 Studied range: 2–2.5 mg How often: Weekly Half-life ~0.5–2 hours
- [VIP](https://pepvault.app/peptides/vip) Vasoactive Intestinal Peptide · VIP neuropeptide Studied range: 50 mcg How often: 2× daily Half-life ~2 min IV

## Growth hormone 14

- [CJC-1295 no DAC](https://pepvault.app/peptides/cjc-1295-no-dac) Modified GRF 1-29 · Mod GRF 1-29 · CJC-1295 without DAC Studied range: 100–200 mcg How often: 2–3× daily Half-life ~30 min
- [CJC-1295 with DAC](https://pepvault.app/peptides/cjc-1295-with-dac) CJC-1295 DAC · DAC:GRF Studied range: 1–2 mg How often: Weekly Half-life ~6–8 days
- [Follistatin-344](https://pepvault.app/peptides/follistatin-344) Follistatin · FST-344 · FS-344 · Follistatin 344 Studied range: 100–200 mcg How often: Daily Half-life: no figure
- [Fragment 176-191](https://pepvault.app/peptides/fragment-176-191) HGH Fragment 176-191 · HGH Frag · AOD Fragment Studied range: 250–500 mcg How often: Daily Half-life ~30 min
- [GHRP-2](https://pepvault.app/peptides/ghrp-2) Growth Hormone Releasing Peptide-2 · Pralmorelin Studied range: 100–300 mcg How often: 2–3× daily Half-life ~30 min
- [GHRP-6](https://pepvault.app/peptides/ghrp-6) Growth Hormone Releasing Peptide-6 Studied range: 100–300 mcg How often: 2–3× daily Half-life ~20 min
- [Hexarelin](https://pepvault.app/peptides/hexarelin) Examorelin Studied range: 100–200 mcg How often: 2–3× daily Half-life ~55–70 min
- [HGH](https://pepvault.app/peptides/hgh) GH · rHGH · Human Growth Hormone · Growth Hormone · Somatropin · hGH Studied range: 1–4 IU How often: Daily Half-life ~3-4 hours
- [IGF-1 LR3](https://pepvault.app/peptides/igf-1-lr3) Long R3 IGF-1 · LR3 IGF-1 · LongR3-IGF-I · Long [Arg3] IGF-I · IGF1 LR3 · IGF-1 Long R3 Studied range: 20–50 mcg How often: Daily Half-life: no figure
- [Ipamorelin](https://pepvault.app/peptides/ipamorelin) IPAM Studied range: 200–300 mcg How often: 2–3× daily Half-life ~2 hours
- [MK-677](https://pepvault.app/peptides/mk-677) Ibutamoren · Nutrobal · MK677 · Ibutamoren Mesylate Studied range: 10–25 mg How often: Daily Half-life ~24 hours
- [PEG-MGF](https://pepvault.app/peptides/peg-mgf) Mechano Growth Factor · MGF · PEGylated MGF · IGF-1Ec · IGF-1 Ec peptide · MGF E-peptide Studied range: 200–400 mcg How often: 2–3× weekly Half-life: no figure
- [Sermorelin](https://pepvault.app/peptides/sermorelin) GHRH 1-29 · GRF 1-29 Studied range: 200–500 mcg How often: Daily Half-life ~11–12 min
- [Tesamorelin](https://pepvault.app/peptides/tesamorelin) Egrifta Studied range: 1–2 mg How often: Daily Half-life ~8–11 min

## Metabolic & GLP-1 15

- [5-Amino-1MQ](https://pepvault.app/peptides/5-amino-1mq) 5-A-1MQ · 5Amino1MQ · 5-Amino-1-methylquinolinium Studied range: 50–100 mg How often: Daily Half-life: no figure
- [Cagrilintide](https://pepvault.app/peptides/cagrilintide) Cagri · AM833 · NNC0174-0833 Studied range: 0.25–2.4 mg How often: Weekly Half-life ~1 week
- [CagriSema](https://pepvault.app/peptides/cagrisema) Cagrilintide/semaglutide · Cagrilintide-semaglutide · Cagri-Sema · Cagri + Sema Studied range: 0.25–2.4 mg How often: Weekly Half-life: no figure
- [Dulaglutide](https://pepvault.app/peptides/dulaglutide) Trulicity · LY2189265 · Dula Studied range: 0.75–4.5 mg How often: Weekly Half-life ~5 days
- [Liraglutide](https://pepvault.app/peptides/liraglutide) Victoza · Saxenda · Liraglutide injection Studied range: 0.6–3 mg How often: Daily Half-life ~13 hours
- [Mazdutide](https://pepvault.app/peptides/mazdutide) IBI362 · LY3305677 · Xinermei Studied range: 2–6 mg How often: Weekly Half-life ~10 days
- [Orforglipron](https://pepvault.app/peptides/orforglipron) Foundayo · LY3502970 · Orfo Studied range: 0.8–17.2 mg How often: Daily Half-life ~29–49 hours
- [Oxytocin](https://pepvault.app/peptides/oxytocin) OT · Love hormone · Oxytocin nasal Studied range: 10–40 IU How often: 1–2× daily Half-life ~1–6 min
- [Pemvidutide](https://pepvault.app/peptides/pemvidutide) ALT-801 Studied range: 1.2–2.4 mg How often: Weekly Half-life: no figure
- [Retatrutide](https://pepvault.app/peptides/retatrutide) LY3437943 Studied range: 1–12 mg How often: Weekly Half-life ~6 days
- [Semaglutide](https://pepvault.app/peptides/semaglutide) Ozempic · Wegovy Studied range: 0.25–2.4 mg How often: Weekly Half-life ~1 week
- [Semaglutide (oral)](https://pepvault.app/peptides/semaglutide-oral) Rybelsus · Wegovy pill · Ozempic pill · Oral semaglutide Studied range: 1.5–25 mg How often: Daily Half-life ~1 week
- [SLU-PP-332](https://pepvault.app/peptides/slu-pp-332) SLU PP 332 · SLUPP332 · SLU-PP332 Studied range: 250–1000 mcg How often: Daily Half-life: no figure
- [Survodutide](https://pepvault.app/peptides/survodutide) BI 456906 · BI456906 · Survo Studied range: 0.3–6 mg How often: Weekly Half-life: no figure
- [Tirzepatide](https://pepvault.app/peptides/tirzepatide) Mounjaro · Zepbound · LY3298176 Studied range: 2.5–15 mg How often: Weekly Half-life ~5 days

## Longevity 13

- [DSIP](https://pepvault.app/peptides/dsip) Delta Sleep-Inducing Peptide · Delta sleep peptide Studied range: 200–400 mcg How often: Daily Half-life: no figure
- [Epitalon](https://pepvault.app/peptides/epitalon) Epithalamin · Tetrapeptide AEDg · Epithalon Studied range: 5–10 mg How often: Daily Half-life: no figure
- [FOXO4-DRI](https://pepvault.app/peptides/foxo4-dri) FOXO4-p53 DRI peptide · Senostatic peptide Studied range: 1–2 mg How often: 3× weekly Half-life: no figure
- [Glutathione](https://pepvault.app/peptides/glutathione) GSH · L-Glutathione · Reduced glutathione · Glutathione injection Studied range: 100–600 mg How often: Daily Half-life ~14 min
- [Humanin](https://pepvault.app/peptides/humanin) HN · Mitochondrial-derived peptide Studied range: 2–4 mg How often: Weekly Half-life: no figure
- [Klotho](https://pepvault.app/peptides/klotho) α-Klotho · Alpha Klotho · Klotho protein Studied range: 0.01–0.1 mg How often: Weekly Half-life: no figure
- [MOTS-c](https://pepvault.app/peptides/mots-c) Mitochondrial Open Reading Frame of the 12S rRNA-c Studied range: 5–10 mg How often: 2–3× weekly Half-life: no figure
- [NAD+](https://pepvault.app/peptides/nad) Nicotinamide adenine dinucleotide · NAD · NAD plus Studied range: 50–100 mg How often: Daily Half-life: no figure
- [NMN](https://pepvault.app/peptides/nmn) Nicotinamide Mononucleotide · Beta-NMN · NMN supplement Studied range: 250–1000 mg How often: Daily Half-life: no figure
- [Pinealon](https://pepvault.app/peptides/pinealon) EDR peptide · Tripeptide-4 · Glu-Asp-Arg Studied range: 100–200 mcg How often: Daily Half-life: no figure
- [SNAP-8](https://pepvault.app/peptides/snap-8) Acetyl octapeptide-3 · Acetyl octapeptide-1 · Snap 8 Studied range: 3–10% How often: 1–2× daily Half-life: no figure
- [SS-31](https://pepvault.app/peptides/ss-31) Elamipretide · Szeto-Schiller 31 · MTP-131 Studied range: 2–4 mg How often: Daily Half-life: no figure
- [Vesugen](https://pepvault.app/peptides/vesugen) KED peptide · Lys-Glu-Asp · Vezugen Studied range: No reference dose How often: Daily Half-life: no figure

## Cognitive 8

- [Adamax](https://pepvault.app/peptides/adamax) Studied range: No reference dose How often: Daily Half-life: no figure
- [Cerebrolysin](https://pepvault.app/peptides/cerebrolysin) FPE 1070 · Cerebrolysin injection Studied range: 5–10 ml How often: Daily Half-life: no figure
- [Dihexa](https://pepvault.app/peptides/dihexa) PNB-0408 · N-hexanoic-Tyr-Ile-(6) aminohexanoic amide Studied range: 10–30 mg How often: Daily Half-life: no figure
- [N-Acetyl Semax Amidate](https://pepvault.app/peptides/n-acetyl-semax-amidate) NA Semax Amidate · NASA peptide · Semax Amidate Studied range: 100–600 mcg How often: Daily Half-life: no figure
- [NSI-189](https://pepvault.app/peptides/nsi-189) NSI189 · NSI 189 phosphate Studied range: 40–80 mg How often: Daily Half-life ~17–20 hours
- [P21](https://pepvault.app/peptides/p21) CNTF analog · P-21 peptide Studied range: 100–300 mcg How often: Daily Half-life: no figure
- [Selank](https://pepvault.app/peptides/selank) Tuftsin analogue · TP-7 Studied range: 250–500 mcg How often: Daily Half-life ~10 min in blood
- [Semax](https://pepvault.app/peptides/semax) ACTH 4-7 Pro8Gly9Pro10 · N-acetyl Semax Studied range: 200–900 mcg How often: Daily Half-life: no figure

## Sexual health 6

- [Enclomiphene](https://pepvault.app/peptides/enclomiphene) Androxal · Trans-clomiphene · Enclomiphene citrate Studied range: 12.5–25 mg How often: Daily Half-life ~10 hours
- [Gonadorelin](https://pepvault.app/peptides/gonadorelin) GnRH · Gonadotropin-releasing hormone · Gonadorelin acetate Studied range: 100 mcg How often: 2–3× weekly Half-life ~2–10 min
- [Kisspeptin-10](https://pepvault.app/peptides/kisspeptin-10) KP-10 · Kisspeptin · Metastin fragment Studied range: 50–500 mcg How often: 2–3× weekly Half-life ~4 min
- [Melanotan I](https://pepvault.app/peptides/melanotan-i) MT-1 · MT1 · Melanotan 1 · Afamelanotide · Scenesse · CUV1647 · NDP-MSH Studied range: 250–1000 mcg How often: Daily Half-life ~0.8–1.7 hours
- [Melanotan II](https://pepvault.app/peptides/melanotan-ii) MT-2 · MT2 · Melanotan 2 Studied range: 250–500 mcg How often: Daily Half-life: no figure
- [PT-141](https://pepvault.app/peptides/pt-141) Bremelanotide · PT141 · Vyleesi Studied range: 0.5–2 mg How often: As needed Half-life ~2.7 hours

## Free tools

- [The Dose Guide](https://pepvault.app/lab/dosage)
- [Reconstitution Lab (3D)](https://pepvault.app/lab)
- [Injection guide (3D)](https://pepvault.app/lab/injection)
- [Peptide Sky (3D)](https://pepvault.app/lab/sky)
- [Peptide tier list](https://pepvault.app/lab/tiers)
- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [Half-life & active level](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)

## Choosing an app?

- [Compare peptide tracker apps](https://pepvault.app/best-peptide-tracker-apps)
- [Peptide vial tracker app](https://pepvault.app/peptide-vial-tracker-app)

## Compare peptides

- [All peptide comparisons](https://pepvault.app/peptides/compare)
- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [BPC-157 vs TB-500](https://pepvault.app/peptides/compare/bpc-157-vs-tb-500)
- [CJC-1295 no DAC vs Ipamorelin](https://pepvault.app/peptides/compare/cjc-1295-no-dac-vs-ipamorelin)
- [Selank vs Semax](https://pepvault.app/peptides/compare/selank-vs-semax)

PepVault for iPhone

## Track any of these in PepVault

Log doses, manage your vials, plan titrations, and watch your protocol come together. 7 days free on the yearly plan for new subscribers.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=peptides-cta&mt=8)

[Open the calculator](https://pepvault.app/tools/reconstitution-calculator) [Explore the live demo](https://pepvault.app/login)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault